Recent Finacing
Recent Raise
Shize Biopharma develops off-the-shelf, allogeneic iPSC-derived cell therapies targeting central nervous system diseases such as Parkinson’s disease and ALS.
Focus Areas
Recent Investors
Total Raised
Funding round
See the team members at 士泽生物 - Shize Biopharmaceutical (Suzhou) Co., Ltd.
